Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0369-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0368-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0367-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0366-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0365-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 10 mg/320 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0364-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 5 mg/320 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0363-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 10 mg/160 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0362-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 5 mg/160 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0361-2019Class IICompletedJan 16, 2019OZURDEXGMP Deviations: A silicone particulate was noted in Ozurdex.Allergan, PLC. · D-0387-2019Class IITerminatedJan 16, 2019Cefdinir for Oral Suspension USPCGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.Lupin Pharmaceuticals Inc. · D-0376-2019Class IITerminatedJan 16, 2019Cefdinir for Oral Suspension USPCGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.Lupin Pharmaceuticals Inc. · D-0375-2019Class IITerminatedJan 16, 20190.9% Buffered Lidocaine HClSubpotentPharMEDium Services, LLC. · D-0374-2019Class ITerminatedJan 16, 2019Vecuronium Bromide for Injection 20 mg* *1mg/mL when reconstituted to 20 mL LyophilizedPresence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.Sun Pharmaceutical Industries, Inc. · D-0373-2019Class ITerminatedJan 16, 2019Vecuronium Bromide for Injection 10 mg*Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.Sun Pharmaceutical Industries, Inc. · D-0372-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0358-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0357-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0356-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0355-2019Class IITerminatedJan 16, 2019Cidofovir Injection 375mg/5mLLack of Assurance of Sterility: complaints received about dried powder on the outside of bottleHeritage Pharmaceuticals, Inc. · D-0352-2019Class IITerminatedJan 16, 2019Dianeal Low CalciumLack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.Baxter Healthcare Corporation · D-0351-2019Class IITerminatedJan 16, 2019Estradiol Vaginal InsertsDefective Delivery System: Customer complaints of malfunctioning plunger of the applicatorGlenmark Pharmaceuticals Inc., USA · D-0350-2019Class IITerminatedJan 9, 2019Lidocaine gel 1%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0408-2019Class IITerminatedJan 9, 2019Glutathione liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0407-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.05%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0406-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0405-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.5%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0404-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 1%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0403-2019Class IITerminatedJan 9, 2019Vitamin B12 liquid 1000mcg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0402-2019Class IITerminatedJan 9, 2019Testosteron Cypionate liquid 200mg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0401-2019Class IITerminatedJan 9, 2019Methocarbamol liquid 100mg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0400-2019Class IITerminatedJan 9, 2019MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vialLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0399-2019Class IITerminatedJan 9, 2019Lidocaine/Epinepherine liquid 1%/ 1:1000Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0398-2019Class IITerminatedJan 9, 2019Lidocaine gel 2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0397-2019Class IITerminatedJan 9, 2019Hydroxyprogesterone liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0396-2019Class IITerminatedJan 9, 2019HCG liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0395-2019Class IITerminatedJan 9, 2019Glutathione liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0394-2019Class IITerminatedJan 9, 2019Epinephrine liquid 1:1000Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0393-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0392-2019Class IITerminatedJan 9, 2019Nitrofurantoin Oral SuspensionSubpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.Lupin Somerset · D-0346-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.